Lingyun Lyu

University of Pittsburgh

Papers

1

Total Citations

12

H-Index

1

About

Dr. Lingyun Lyu is a dedicated clinical researcher whose work centers on optimizing quality of life outcomes for patients with head and neck cancers, particularly oropharyngeal squamous cell carcinoma (OPSCC). Her most cited study, a 2021 cross-sectional analysis of advanced-stage OPSCC patients treated with multimodal therapies, directly compared the long-term effects of radiation therapy and transoral robotic surgery on swallowing function and overall quality of life. This work, with 12 citations, provides crucial insights for clinicians navigating the complex trade-offs between oncologic control and functional preservation. Dr. Lyu’s research is distinguished by its patient-centered focus, using validated QOL instruments to move beyond survival metrics and capture the lived experience of cancer survivors. By highlighting the specific treatment factors that most impact post-treatment well-being, her findings help guide more personalized, less debilitating treatment plans. Her contributions are especially valuable for students and clinicians in otolaryngology, radiation oncology, and speech-language pathology, offering an evidence-based framework for shared decision-making in advanced oropharyngeal cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Quality of life after radiation and transoral robotic surgery in advanced oropharyngeal cancer
12 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: University of Pittsburgh

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago